# Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

> **NCT01623466** · PHASE1,PHASE2 · COMPLETED · sponsor: **Agile Therapeutics** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** levonorgestrel

## Key facts

- **NCT ID:** NCT01623466
- **Lead sponsor:** Agile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623466, "Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01623466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*